Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
CEO Dave
since
auto-detected in 1 stories
12 days ago
Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an interview with CNBC.
page 1 of 1